Table 2.

Cell development in LTC




linneg CD34+

ALDHbr CD34+

ALDHneg CD34+

P
Cell expansion in primary LTC, -fold     
    Expansion*     .0625  
        Mean ± SD   4083 ± 1922   3664 ± 2120   827 ± 1142   
        Median   3479   3350   285   
Myeloid CFUs/100 initiating cells     
    Primary LTC     .004  
        Mean ± SD   260.9 ± 159   309.2 ± 180   4.85 ± 10.4   
        Median   294.9   349.4   0   
    Secondary LTC     .004  
        Mean ± SD   13.9 ± 8.5   54.6 ± 95.1   0.36 ± 0.56   
        Median
 
9.74
 
25.9
 
0
 

 



linneg CD34+

ALDHbr CD34+

ALDHneg CD34+

P
Cell expansion in primary LTC, -fold     
    Expansion*     .0625  
        Mean ± SD   4083 ± 1922   3664 ± 2120   827 ± 1142   
        Median   3479   3350   285   
Myeloid CFUs/100 initiating cells     
    Primary LTC     .004  
        Mean ± SD   260.9 ± 159   309.2 ± 180   4.85 ± 10.4   
        Median   294.9   349.4   0   
    Secondary LTC     .004  
        Mean ± SD   13.9 ± 8.5   54.6 ± 95.1   0.36 ± 0.56   
        Median
 
9.74
 
25.9
 
0
 

 

LTCs were established with linneg SSClo CD34+, linneg SSClo ALDHbr CD34+, linneg SSClo ALDHneg CD34+, and linneg SSClo ALDHbr CD34neg cells, as described in “Materials and methods.” Fifty to 500 cells were used to initiate the primary LTC. In some cultures, the total expansion of CD45+ cells was estimated by flow cytometry after 5 weeks.

*

Linneg SSClo ALDHbr CD34neg cells were not supported under these culture conditions. Statistical comparisons (P) were drawn between the linneg SSClo ALDHbr CD34+ and the linneg SSClo ALDHneg CD34+ cell fractions using paired, 1-tailed nonparametric analyses (Wilcoxon signed rank test).

Mean (±SD) and median frequencies for myeloid CFUs were normalized per 100 cells that were used to initiate the culture.

Close Modal

or Create an Account

Close Modal
Close Modal